The Latest Breaking News from Alzheimer Disease

Kisunla is first new treatment registered by TGA in 25 years but could cost patients more than $80,000 and less than one in five will be eligible

A new study has found the herpes simplex virus type 1 (HSV-1), which causes cold sores, may be linked to the development of Alzheimer’s disease.

Researchers made a surprising connection between certain viral diseases and Alzheimer’s

A study found that people who had suffered the herpes virus had an 80% increased risk of Alzheimer’s disease.

Auguste Deter was born 175 years ago on May 16, 1850. Though the story of her life is not widely known, it should be. Through her suffering and dignity, Deter puts a much-needed human face on the tragedy of Alzheimer’s disease (AD), one of the most important medical problems currently…

A new study has highlighted the complex emotions and ethical dilemmas of learning your future risk of Alzheimer’s disease. Among 274 healthy research participants from the US aged 65 and over, 40% declined to receive their personal risk estimates – despite having initially expressed an interest in doing so.

Millions of older adults take five or more prescription drugs every day to manage chronic illnesses. While polypharmacy is often necessary, this practice has also been linked to many negative health outcomes in older adults – including memory problems, increased risk of falls and greater frailty.

ANALYSIS: Menopause can provide early warning signs, write Jasper Crockford, Maryam Ghahremani and Zahinoor Ismail

Diabetes treatments are offering a glimmer of hope for a degenerative brain condition set to affect more than 800,000 Australians by the middle of the century.

Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and often strikes people in the prime of their lives. Treatment options remain limited.

The results boost hopes similar treatments being developed to target more common forms of Alzheimer's - that appear when people reach their sixties, seventies and eighties - might also be effective.